Influenza virus vaccine trivalent - Il-Yang

Drug Profile

Influenza virus vaccine trivalent - Il-Yang

Alternative Names: Il-Yang flu vaccine; Inactivated Split Influenza Vaccine -IL-Yang

Latest Information Update: 01 Jul 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Il-Yang
  • Class Influenza virus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Influenza virus infections

Most Recent Events

  • 01 Feb 2015 Registered for Influenza virus infections (Prevention, In adults, In adolescents, In children, In infants) in South Korea (IM)
  • 01 Sep 2012 Phase-I clinical trials in Influenza virus infections (in healthy volunteers; prevention) in South Korea (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top